A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score
PLOS One · 06.01.2026 · 21 (1) · e0324241
DOI: 10.1371/journal.pone.0324241 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, online erschienen am 06.01.2026. Verfasst von Kim Engler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Medication Adherence, Patient Reported Outcome Measures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian HIV Trials Network, Canadian Institutes of Health Research, Strategy for Patient-Oriented Research, Merck Canada.
Abstract (Originalsprache)
Adherence to antiretroviral therapy (ART) is a priority in HIV care. Our goal was to develop and validate a new, short patient-reported outcome measure to screen for barriers to daily oral ART adherence in HIV care in Canada and France. The overarching design was that of a multi-phase, multi-site instrument development project. It involved a previously published qualitative research synthesis (to develop a conceptual framework from which to generate items). Here, we present the results of cognitive interviews (for content validity testing of the preliminary items) and of a longitudinal survey-based study where the revised 7-item instrument (the I-Score) was administered at two timepoints (baseline, 4 weeks), along with five indirect measures of ART adherence, including self-reported HIV viral load and, for a subset of Montreal participants, plasma viral load. The survey data was used to analyze the instrument’s measurement properties, namely structural validity (e.g., with Pearson inter-item correlations); construct validity, including cross-cultural validity, for a variety of sociodemographic groups (with receiver operating curve (ROC) analyses and areas under the curve (AUC); reliability (with the intraclass correlation coefficient (ICC)); and measurement error (with the standard error of measurement (SEM)). Study participants were adults living with HIV on antiretroviral therapy recruited from hospital-based infectious disease centers and community-based organizations in Montreal, Toronto, and Paris. The qualitative synthesis of 41 studies led to a framework composed of 6 barrier domains. One item was generated per domain. The 6-item measure was submitted to cognitive testing with 12 adults living with HIV, leading to several changes, including the division of one item into two, creating a 7-item measure. Overall, 305 adults living with HIV participated in the survey. Inter-item correlations were low to moderate, suggesting no redundant items. Among conclusive results, AUC’s were all above the predefined threshold (≥ 0.70) for self-reported viral load and plasma viral load for the global sample and across all subgroups examined. The ICC, at 0.81, was also above the predefined threshold (≥ 0.70). The SEM was 0.43. Overall, the evidence generated supports the 7-item I-Score measure’s content validity, construct validity/cross-cultural validity, reliability, and acceptable measurement error, in its specified context of use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Mathematics and Statistics, University of Montreal, Montreal, Quebec, Canada.
- Division of Infectious Diseases, St. Michael's Hospital, Toronto, Canada.
- Department of Medicine, University of Toronto, Toronto, Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
- Sorbonne Université, Inserm, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Paris, France.
ORCID-Profile: Kim Engler, Darrell H S Tan
Förderung
- Canadian HIV Trials Network, Canadian Institutes of Health Research
- Strategy for Patient-Oriented Research
- Merck Canada
- MSDAVENIR
Zitieren
APA
Engler, K., Lessard, D., Vicente, S., Tan, D. H. S., Lacombe, K., & Lebouché, B. (2026). A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score. PLOS One, 21(1), e0324241. https://doi.org/10.1371/journal.pone.0324241
Vancouver
Engler K, Lessard D, Vicente S, Tan DHS, Lacombe K, Lebouché B. A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score. PLOS One. 2026;21(1):e0324241. doi:10.1371/journal.pone.0324241
BibTeX
@article{Engler2026,
author = {Engler, Kim and Lessard, David and Vicente, Serge and Tan, Darrell H S and Lacombe, Karine and Lebouché, Bertrand},
title = {A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {1},
pages = {e0324241},
doi = {10.1371/journal.pone.0324241}
}
EUVIMED